The regulatory challenge of counterfeit medicines

被引:0
|
作者
Lee, M. G. [1 ]
机构
[1] Med & Healthcare Prod Regulatory Agcy, BP & Lab Serv, London SW8 5NQ, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
201
引用
收藏
页码:A74 / A74
页数:1
相关论文
共 50 条
  • [1] Counterfeit medicines
    Keller-Stanislawski, Brigitte
    Paeschke, Norbert
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2017, 60 (11) : 1185 - 1187
  • [2] Routine quality control of medicines in developing countries: Analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania
    Hoellein, Ludwig
    Kaale, Eliangiringa
    Mwalwisi, Yonah H.
    Schulze, Marco H.
    Holzgrabe, Ulrike
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2016, 76 : 60 - 70
  • [3] APPA® Project: counterfeit medicines
    Brusa, P.
    Rolando, E.
    Bellobuono, I.
    Reynaldi, S. M.
    Germano, A.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 : 59 - 60
  • [4] COUNTERFEIT MEDICINES - THE CASE FOR ACTION
    VOLANS, GN
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1992, 11 (01): : 3 - 3
  • [5] THE COUNTERFEIT MEDICINES - A SILENT EPIDEMIC
    Bahjat, Safaa
    WORLD FAMILY MEDICINE, 2007, 5 (08): : 16 - 17
  • [6] The real cost of counterfeit medicines
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2010, 10 (09): : 585 - 586
  • [7] Packaging analysis of counterfeit medicines
    Degardin, Klara
    Guillemain, Aurelie
    Klespe, Philippe
    Hindelang, Florine
    Zurbach, Raphael
    Roggo, Yves
    FORENSIC SCIENCE INTERNATIONAL, 2018, 291 : 144 - 157
  • [8] Minilabs combat counterfeit medicines
    不详
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2012, 38 : IX - X
  • [9] Substandard medicines: a greater problem than counterfeit medicines?
    Sammons, Helen M.
    Choonara, Imti
    BMJ PAEDIATRICS OPEN, 2017, 1 (01)